27
Algal biotechnology: facts, fiction and future prospects John G Day Coordination Centre: Scottish Association for Marine Science, Oban, Scotland T: +44 (0)1631 559000 F: +44 (0)1631 559001 E: [email protected] W: www.biomara.org Project supported by the INTERREG IVA Programme managed by SEUPB

Algal biotechnology: facts, fiction and future prospectsAlgal biotechnology: facts, fiction and future prospects John G Day Coordination Centre: Scottish Association for Marine Science,

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

  • Algal biotechnology: facts, fiction and future prospects

    John G Day

    Coordination Centre:Scottish Association for Marine Science, Oban, Scotland

    T: +44 (0)1631 559000F: +44 (0)1631 559001E: [email protected]: www.biomara.org

    Project supported by the INTERREG IVA Programme managed by SEUPB

  • Why bother with Algae?

    • Algae are debatably the most diverse group of organisms on earth

  • Why bother with Algae?• Algae are responsible for the oxygen in every second breath you take• They form the basis of the food chain for approx 70% of the worlds biomass• Without algae the world dies!

  • If algae are such a big deal, how come we never hear about them?

  • Algal exploitation: Historical perspective

    Seaweed being 

    harvested in 19th century for use as a fertiliser

  • Kelp Burning: a biotechnology process from the 18th & 19th centuries to produce soda, potash & 

    iodine

    .

  • Phyco‐colloidsAgar7,500 tonnes of agar with a wholesale value of US$250 million. 

    Alginates>$120M excluding China

    Carrageenan> 50,000 tonnes in 2007/8 with a value of over US$600 million (excluding China) 

  • Alginate: A Natural Chemicalwith Diverse Uses

    • Alginates are jelly‐like carbohydrates used for water retention, gelling, emulsifying and stabilising.

    • Used in food, drink, cosmetics, medical and chemical industries

    • Currently there are some 250 applications

  • ISP Alginates Plant, Girvan

    Girvan one of the world’s largest alginate plant

  • More than 20 species are used in everyday cookery in Japan, six of them since the 8th century.

    Seaweed accounts for some 10% of the Japanese diet

    Most important food species in Japan are Nori (Porphyraspecies), Kombu (Laminaria species), and Wakame (Undaria pinnatifida)

    Nori a $1 billion Industry

  • Seaweed Products

    http://www.tavay-organics.fsnet.co.uk/soil_improver.html

  • What about Microalgae?

  • Historical use of algae:

    Food-supplement in central Africa & Central America

    Spirullina /Arthrospira

  • •Chaetoceros calcitrans 

    •Isochrysis sp. (Tahitian) 

    •Nannochloris atomus

    •Pavlova lutheri CCAP 

    •Rhinomonas reticulata var. reticulata

    •Skeletonema costatum

    •Tetraselmis chui

    Thalassiosira pseudonana

    Aquaculture a multi-billion $ Industry

  • Current uses of microalgae“Witchcraft”

    Dietary supplements

    Health foods

    Neutraceuticals

    Pigments & specialist chemicals

  • Microalgae & cyanobacteriaCOMMERCIALLY exploited and 

    grown at large scale

    Chlorella spp

    Aphanizomenon flos aquae

    Arthrospira/ Spirullina spp

    Dunaliella salina

    Haematococcus pluvialis

    Cryptothecodinium cohenii

  • Production systems: Open

  • Production systems: closed

  • Future Prospects – Industrial needs• Pharmaceutical

    • New bio‐active molecules with novel modes of action / chemical structure  (new chemical scaffolds).

    • Need for new drugs (emerging diseases / drug resistance)

    • Nutraceuticals• Functional foods (Fatty acids ‐micro algae) – heart 

    health, obesity control, immuno health.• Probiotics (animal and human)• Anti‐oxidants

    • Industrial• Biofuels• New sources of enzymes – biotransformation of 

    chemicals• .New Cosmetics (cosmoceuticals) 

  • Future product areas

    • Biofuels• Foods• Bioactives/ Pharmaceuticals

    • Novel enzymes• Specialist chemicals• Green fertilizers• Green insecticides • Bioremediation

  • Bioactives: pharmaceuticals

    •They are, as yet, a largely unexploited biotechnological “treasure store”

  • ConstraintsTechnological constraints• Production systems engineering problems• Downstream processing/ product

    extraction/purification/formulation• Production strain productivity• Production strain stability

    Can you protect your IP?• Yes… Can you afford to defend challenges to your patents?• No… Can you protect your know-how by some other method?

    Do not forget the Convention on Biological Diversity (CBD) & the UN Convention on the Law of the Sea (UNCLOS)!• Are you a BioPirate?

  • Future prospectsAlgal production- parallels with penicillin production:

    March 14, 1942 the first patient was treated for streptococcal septicaemia with U.S.-made penicillin used half of the total supply produced.

    By Spring of 1944 the USA to produce 2.3 million doses in time for the invasion of Normandy.

    $1000/Kg $100/Kg $10/Kg $1/Kg c/Kg

  • Reality check:Market driven or technology driven?

    Production economics…

    Investment…

  • Conclusions:

    There must be a market need.

    Production must be reliable AND COST EFFECTIVE.

    The technology must be robust and reliable.

    Ideally the technology should be a platform for a suite of products.

    The technology should be protectable.

    Get it right and……. $

    Algal biotechnology: facts, fiction and future prospects Algal exploitation: �Historical perspective.Alginate: A Natural Chemical�with Diverse UsesISP Alginates Plant, GirvanFuture Prospects – Industrial needsFuture product areasBioactives: pharmaceuticalsConstraintsFuture prospectsAlgal biotechnology: facts, fiction and future prospects Algal exploitation: �Historical perspective.Alginate: A Natural Chemical�with Diverse UsesISP Alginates Plant, GirvanFuture Prospects – Industrial needsFuture product areasBioactives: pharmaceuticalsConstraintsFuture prospects